0001562180-24-005606.txt : 20240703
0001562180-24-005606.hdr.sgml : 20240703
20240703172730
ACCESSION NUMBER: 0001562180-24-005606
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240701
FILED AS OF DATE: 20240703
DATE AS OF CHANGE: 20240703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thomas Monica R.
CENTRAL INDEX KEY: 0001978347
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38096
FILM NUMBER: 241100992
MAIL ADDRESS:
STREET 1: 700 PARK OFFICES
STREET 2: SUITE 200
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER NAME:
FORMER CONFORMED NAME: Thomas Monica
DATE OF NAME CHANGE: 20230518
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: G1 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001560241
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 263648180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 PARK OFFICES DRIVE
STREET 2: SUITE 200
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-213-9835
MAIL ADDRESS:
STREET 1: 700 PARK OFFICES DRIVE
STREET 2: SUITE 200
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: G-Zero Therapeutics, Inc.
DATE OF NAME CHANGE: 20121012
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-07-01
false
0001560241
G1 Therapeutics, Inc.
GTHX
0001978347
Thomas Monica R.
700 PARK OFFICES DRIVE, SUITE 200
RESEARCH TRIANGLE PARK
NC
27709
false
true
false
false
Chief Legal & People Officer
false
Common Stock
2024-07-01
4
A
false
35000.00
0.00
A
144825.00
D
Represents a restricted stock unit ("RSU") award that vests 50% on July 1, 2025 and 50% on July 1, 2026, subject to the Reporting Person's continued service through each applicable vesting date.
Each RSU represents a contingent right to receive one share of Issuer common stock.
Represents (i) 6,850 shares of common stock; (ii) 37,500 RSUs from award granted on May 22, 2023; (iii) 27,975 RSUs from award granted on January 3, 2024; (iv) 37,500 RSUs from award granted on March 20, 2024; and (v) 35,000 RSUs from award granted on July 1, 2024.
/s/ Monica Thomas
2024-07-03